PROLACTIN-PRODUCING PITUITARY TUMOR

Clinical trials for PROLACTIN-PRODUCING PITUITARY TUMOR explained in plain language.

Never miss a new study

Get alerted when new PROLACTIN-PRODUCING PITUITARY TUMOR trials appear

Sign up with your email to follow new studies for PROLACTIN-PRODUCING PITUITARY TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

New hope for patients with Hard-to-Treat pituitary tumors

Disease control Recruiting now

This study is testing whether the drug pasireotide can help control prolactinoma tumors in people who cannot take or don't respond to standard dopamine agonist medications. Researchers will enroll about 10 adults who are not candidates for surgery to see if pasireotide safely low…

Matched conditions: PROLACTIN-PRODUCING PITUITARY TUMOR

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

PROLACTIN-PRODUCING PITUITARY TUMOR

Get alerted when new PROLACTIN-PRODUCING PITUITARY TUMOR trials appear

New hope for patients with Hard-to-Treat pituitary tumors